REDWOOD CITY, Calif., April 09, 2025 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading provider of enzymatic solutions for efficient and scalable therapeutics manufacturing, today announced ...

Already, her company sources at least 80 percent of its products from China—which is staring down the cumulative 104 percent tariff increase from the United States—and no one wants to kick ...

not least to the United States, but these tend to be concentrated among the better educated. All too often the service-sector jobs that have filled the gap left by declining manufacturing have ...

April 09, 2025 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading provider of enzymatic solutions for efficient and scalable therapeutics manufacturing, today announced that Byron Dorgan ...

But there could be silver linings for ASX stocks focused on domestic manufacturing in the United States, one of the key aims the ... towards the expansion of IPX’s Titanium Manufacturing Campus in ...

It is worth considering United Therapeutics (UTHR), which belongs to the Zacks Medical - Drugs industry. This drugmaker has an established record of topping earnings estimates, especially when ...

President Trump signed executive orders aimed at boosting coal production to help revive U.S. manufacturing jobs following international tariffs. NBC News’ Yasmin Vossoughian reports on whether ...

Liquidia faced significant legal challenges from United Therapeutics, delaying the market entry of its PAH drug Yutrepia until after Tyvaso's patent expiry in 2025. Despite tentative FDA approval ...

The United States fashion industry is confronting a challenging landscape as tariffs are now universally applied to imported apparel, eliminating previous avenues for cost mitigation through ...

The United Nations Development Programme (UNDP) in Ukraine with funding from the Government of Sweden, in partnership with the Ministry of Digital Transformation of Ukraine and CDTO Campus, is ...